Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vaccine Clinical TrialPRNewsWire • 10/26/21
New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces Airborne Transmission of SARS-CoV-2 Infection in Animal ModelPRNewsWire • 10/07/21
Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Tablet Vaccine Clinical TrialPRNewsWire • 10/06/21
Did You Acquire (VXRT) Before June 25, 2020? Johnson Fistel Investigates Vaxart; Should Management be Held Accountable for Investors Losses?PRNewsWire • 10/02/21